diclofenac and metoprolol

diclofenac has been researched along with metoprolol in 45 studies

Research

Studies (45)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.22)18.7374
1990's0 (0.00)18.2507
2000's14 (31.11)29.6817
2010's24 (53.33)24.3611
2020's6 (13.33)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Faller, B; Wohnsland, F1
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P1
Jolivette, LJ; Ward, KW1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y1
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Avdeef, A; Tam, KY1
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ1
Bellman, K; Knegtel, RM; Settimo, L1
Artursson, P; Mateus, A; Matsson, P1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Guo, HF; Jin, J; Li, ZR; Liu, ZY; Xie, ZS; Xue, ST; Yi, H; Zhang, L1
Ablad, B; Aurell, M; Kopp, U; Sjölander, M1
Casper, H; Scheil, V; Schwaiger, J; Triebskorn, R1
Golloch, A; Schmidt, TC; Sein, MM; von Sonntag, C1
Bracher, F; Dietrich, S; Laforsch, C; Ploessl, F1
Marison, IW; von Stockar, U; Whelehan, M1
Montforts, M; van den Brandhof, EJ1
Koenen, S; Pinnekamp, J; Tondera, K1
Ehrhard, P; Fahlenkamp, H; Jagemann, P; Launer, M; Lyko, S1
Faber, H; Frensemeier, L; Karst, U; Lareo, PL; Lutze, H; Schmidt, TC; Vogel, M1
Gröner, F; Kloas, W; Ziková, A1
Ahnfelt, E; Axén, N; Lennernäs, H; Sjögren, E1
Behrendt, J; Beier, S; Gulyas, H; Meyer, W; Otterpohl, R; Reich, M1
Baron, MG; Hetheridge, MJ; Jackson, SK; Jha, AN; Mintram, KS; Moody, AJ; Owen, SF; Purcell, WM1
Brunsch, AF; Christoffels, E; Rijnaarts, H; Ter Laak, TL1
Butkovskyi, A; Hernandez Leal, L; Meulepas, RJW; Rijnaarts, HHM; Sevenou, L; Zeeman, G1
Ahmad, S; Baker, D; Gerhard, U; Murnane, D; Spooner, N1
Hohrenk-Danzouma, LL; Klein, M; Lutze, HV; Merkus, VI; Schmidt, TC; Wirzberger, V1
Fernandes, TV; Langenhoff, A; Rijnaarts, H; Tizzani, R; Wu, K; Zweers, H1
Al-Hindi, M; Malli, A; Mansour, F; Mheidli, N1
Bhayani, D; Khan, S; Mehta, P; Naik, H; Nathaniel, TN; Patel, M1

Reviews

2 review(s) available for diclofenac and metoprolol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Occurrence and risk assessment of pharmaceuticals in surface waters of the Middle East and North Africa: A review.
    The Science of the total environment, 2022, Dec-10, Volume: 851, Issue:Pt 2

    Topics: Animals; Anti-Bacterial Agents; Carbamazepine; Child; Diclofenac; Drinking Water; Ecosystem; Environmental Monitoring; Estradiol; Humans; Metoprolol; Pharmaceutical Preparations; Risk Assessment; Spiramycin; Thiamphenicol; Water Pollutants, Chemical

2022

Other Studies

43 other study(ies) available for diclofenac and metoprolol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
    Journal of medicinal chemistry, 2001, Mar-15, Volume: 44, Issue:6

    Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water

2001
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
    Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7

    Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties

2004
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7

    Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
    Bioorganic & medicinal chemistry, 2007, Nov-15, Volume: 15, Issue:22

    Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:4

    Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software

2009
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
    Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9

    Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis

2010
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3

    Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution

2011
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1

    Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests

2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1

    Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity

2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
    Journal of medicinal chemistry, 2014, Apr-10, Volume: 57, Issue:7

    Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2014
Substituted benzothiophene and benzofuran derivatives as a novel class of bone morphogenetic Protein-2 upregulators: Synthesis, anti-osteoporosis efficacies in ovariectomized rats and a zebrafish model, and ADME properties.
    European journal of medicinal chemistry, 2020, Aug-15, Volume: 200

    Topics: Animals; Benzofurans; Bone Morphogenetic Protein 2; Caco-2 Cells; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Inbred BALB C; Molecular Structure; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiophenes; Zebrafish

2020
The role of prostaglandins in the alpha- and beta-adrenoceptor mediated renin release response to graded renal nerve stimulation.
    Pflugers Archiv : European journal of physiology, 1981, Volume: 391, Issue:1

    Topics: Animals; Diclofenac; Dogs; Drug Combinations; Female; Indomethacin; Kidney; Male; Metoprolol; Phenoxybenzamine; Prostaglandins; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Renin; Stimulation, Chemical

1981
Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio).
    Analytical and bioanalytical chemistry, 2007, Volume: 387, Issue:4

    Topics: Animals; Carbamazepine; Carps; Clofibric Acid; Diclofenac; Gills; Kidney; Liver; Metoprolol; Microscopy, Electron, Transmission; Oncorhynchus mykiss

2007
Oxidation of some typical wastewater contaminants (tributyltin, clarithromycin, metoprolol and diclofenac) by ozone.
    Water science and technology : a journal of the International Association on Water Pollution Research, 2009, Volume: 59, Issue:8

    Topics: Clarithromycin; Diclofenac; Kinetics; Metoprolol; Molecular Structure; Oxidation-Reduction; Ozone; Trialkyltin Compounds; Tropical Climate; Waste Disposal, Fluid; Water Pollutants, Chemical

2009
Single and combined toxicity of pharmaceuticals at environmentally relevant concentrations in Daphnia magna--a multigenerational study.
    Chemosphere, 2010, Volume: 79, Issue:1

    Topics: Animals; Carbamazepine; Daphnia; Diclofenac; Environmental Exposure; Ethinyl Estradiol; Metoprolol; Pharmaceutical Preparations; Reproduction; Water Pollutants, Chemical

2010
Removal of pharmaceuticals from water: using liquid-core microcapsules as a novel approach.
    Water research, 2010, Volume: 44, Issue:7

    Topics: Capsules; Carbamazepine; Clofibric Acid; Diclofenac; Environmental Monitoring; Feasibility Studies; Fresh Water; Furosemide; Kinetics; Metoprolol; Pharmaceutical Preparations; Reproducibility of Results; Sulfamethoxazole; Warfarin; Water Pollutants, Chemical; Water Purification; Water Supply

2010
Fish embryo toxicity of carbamazepine, diclofenac and metoprolol.
    Ecotoxicology and environmental safety, 2010, Volume: 73, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Antimanic Agents; Carbamazepine; Diclofenac; Dose-Response Relationship, Drug; Metoprolol; Time Factors; Toxicity Tests; Water Pollutants, Chemical; Zebrafish

2010
Survey monitoring results on the reduction of micropollutants, bacteria, bacteriophages and TSS in retention soil filters.
    Water science and technology : a journal of the International Association on Water Pollution Research, 2013, Volume: 68, Issue:5

    Topics: Bacteria; Bacteriophages; Benzhydryl Compounds; Diclofenac; Filtration; Metoprolol; Phenols; Waste Disposal, Fluid; Water Pollution; Water Purification

2013
Application of CFD modelling at a full-scale ozonation plant for the removal of micropollutants from secondary effluent.
    Water science and technology : a journal of the International Association on Water Pollution Research, 2013, Volume: 68, Issue:6

    Topics: Diatrizoate; Diclofenac; Hydrodynamics; Metoprolol; Models, Theoretical; Oxidants; Ozone; Waste Disposal, Fluid; Water Pollutants, Chemical

2013
Liquid chromatography/mass spectrometry to study oxidative degradation of environmentally relevant pharmaceuticals by electrochemistry and ozonation.
    Journal of chromatography. A, 2014, May-23, Volume: 1343

    Topics: Chromatography, Liquid; Diclofenac; Electrochemical Techniques; Electrodes; Metoprolol; Oxidation-Reduction; Ozone; Tandem Mass Spectrometry; Water Purification

2014
Effects of the pharmaceuticals diclofenac and metoprolol on gene expression levels of enzymes of biotransformation, excretion pathways and estrogenicity in primary hepatocytes of Nile tilapia (Oreochromis niloticus).
    Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2015, Volume: 167

    Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cells, Cultured; Cichlids; Cytochrome P-450 CYP1A1; Diclofenac; Estrogens; Gene Expression Regulation; Genes, MDR; Glutathione Transferase; Hepatocytes; Male; Metoprolol; RNA, Messenger; Vitellogenins; Water Pollutants, Chemical

2015
A miniaturized in vitro release method for investigating drug-release mechanisms.
    International journal of pharmaceutics, 2015, Volume: 486, Issue:1-2

    Topics: Carbamazepine; Computer Simulation; Diclofenac; Drug Delivery Systems; Drug Liberation; Humans; Intestinal Absorption; Metoprolol; Miniaturization; Models, Theoretical; Naproxen

2015
Measured and predicted environmental concentrations of carbamazepine, diclofenac, and metoprolol in small and medium rivers in northern Germany.
    Environmental monitoring and assessment, 2016, Volume: 188, Issue:8

    Topics: Carbamazepine; Chromatography, High Pressure Liquid; Diclofenac; Environmental Monitoring; Forecasting; Germany; Metoprolol; Models, Theoretical; Rivers; Solid Phase Extraction; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical

2016
Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Animals; Atenolol; Biotransformation; Carbamazepine; Diazepam; Diclofenac; Drug Evaluation, Preclinical; Female; Kinetics; Liver; Metoprolol; Models, Animal; Oncorhynchus mykiss; Phenylbutazone; Propranolol; Tandem Mass Spectrometry; Water Pollutants, Chemical; Xenobiotics

2017
Pharmaceutical concentration variability at sewage treatment plant outlets dominated by hydrology and other factors.
    Environmental pollution (Barking, Essex : 1987), 2018, Volume: 235

    Topics: Biodegradation, Environmental; Carbamazepine; Diclofenac; Environmental Monitoring; Germany; Hydrology; Metoprolol; Pharmaceutical Preparations; Rain; Sewage; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical

2018
Micropollutant removal from black water and grey water sludge in a UASB-GAC reactor.
    Water science and technology : a journal of the International Association on Water Pollution Research, 2018, Volume: 77, Issue:3-4

    Topics: Anaerobiosis; Benzopyrans; Bioreactors; Carbon; Diclofenac; Ibuprofen; Metoprolol; Sewage; Triclosan; Waste Disposal, Fluid; Water Pollutants, Chemical

2018
Solid-phase microextraction for assessment of plasma protein binding, a complement to rapid equilibrium dialysis.
    Bioanalysis, 2021, Volume: 13, Issue:14

    Topics: Animals; Blood Proteins; Chromatography, Liquid; Dialysis; Diclofenac; Metoprolol; Propranolol; Protein Binding; Rats; Solid Phase Microextraction; Tandem Mass Spectrometry

2021
Bromide strongly influences the formation of reaction products during the ozonation of diclofenac, metoprolol and isoproturon.
    The Science of the total environment, 2022, Apr-01, Volume: 815

    Topics: Bromides; Diclofenac; Metoprolol; Ozone; Phenylurea Compounds; Water Pollutants, Chemical; Water Purification

2022
Removal processes of individual and a mixture of organic micropollutants in the presence of Scenedesmus obliquus.
    The Science of the total environment, 2022, Sep-10, Volume: 838, Issue:Pt 4

    Topics: Carbamazepine; Chlorophyceae; Clarithromycin; Diclofenac; Metoprolol; Microalgae; Scenedesmus; Wastewater; Water Pollutants, Chemical

2022
Ground-based selected ionizing space radiation effects on stability of APIs and their formulations.
    Journal of pharmaceutical and biomedical analysis, 2022, Oct-25, Volume: 220

    Topics: Ciprofloxacin; Diclofenac; Metoprolol; Protons; Radiation, Ionizing; Space Flight; Tablets

2022